Laboratory diagnosis of pertussis infections: the role of PCR and serology.

This study reports on practical laboratory aspects of pertussis diagnosis. PCR assays were applied to respiratory specimens obtained during a large study of infants (less than 5 months old) admitted to paediatric intensive care units (n = 122), children (less than 15 years old) admitted to paediatric wards (n = 16) and their household contacts (n = 320). Estimation of antibodies to pertussis toxin and culture for Bordetella pertussis were attempted on specimens from the same patients, where available, and the overall utility of the diagnostic PCR assays was assessed by comparison to these results. A PCR assay for the human mitochondrial cytochrome oxidase (HMCO) gene was used for quality control of the extracted samples and an internal process control (IPC) was included in each sample to test for PCR inhibition. Four of 458 samples were considered unsuitable (three HMCO negative, one IPC negative) and excluded from further analyses. Positive PCR results were considered valid if they were either (i) positive for both of two B. pertussis gene targets (pertussis toxin S1 promoter and the insertion element IS481), i.e. consensus PCR positive, or (ii) repeatably positive in only one assay. Using these criteria, 52 of 454 (11.5 %) samples were considered as PCR positive for B. pertussis. Six of 356 samples were culture-positive for B. pertussis, 1/88 infants, 3/14 children and 2/254 contacts, giving an overall isolation rate of 1.7 %. Using these data, PCR gave an almost fivefold increase in diagnostic yield compared with culture (McNemar's test; P < 0.0001). Sera from 9/111 infants, 5/10 children and 14/210 contacts were positive. Serology and PCR results showed a high level of agreement (113/121) for infants and children. PCR demonstrated a significant improvement in diagnostic yield over culture. Serological testing also resulted in a significant increase in diagnostic yield compared to culture alone. PCR is a useful technique, but validity of results must be assured by careful control. Rapid diagnosis of B. pertussis infection particularly in infants by PCR, together with serological assays, can enhance surveillance systems for pertussis in all age groups.

[1]  A. Nardone,et al.  Sero-epidemiology of Bordetella pertussis in England and Wales. , 2004, Vaccine.

[2]  J. Schellekens,et al.  European Sero-Epidemiology Network: standardisation of the assay results for pertussis. , 2003, Vaccine.

[3]  B. Barrell,et al.  Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica , 2003, Nature Genetics.

[4]  Q. Mok,et al.  Severe and unrecognised: pertussis in UK infants , 2003, Archives of disease in childhood.

[5]  S. Salmaso,et al.  Analogous IgG subclass response to pertussis toxin in vaccinated children, healthy or affected by whooping cough. , 2003, Vaccine.

[6]  M. Brisson,et al.  Deaths from pertussis are underestimated in England , 2002, Archives of disease in childhood.

[7]  M. Loeffelholz,et al.  Real-Time PCR Assay Targeting IS481of Bordetella pertussis and Molecular Basis for Detecting Bordetella holmesii , 2001, Journal of Clinical Microbiology.

[8]  D. Fleming,et al.  Serological evidence of pertussis in patients presenting with cough in general practice in Birmingham. , 2000, Communicable disease and public health.

[9]  J. Blondeau,et al.  Detection of Bordetella pertussis in a clinical laboratory by culture, polymerase chain reaction, and direct fluorescent antibody staining; accuracy, and cost. , 2000, Diagnostic microbiology and infectious disease.

[10]  R. Matthews,et al.  Bordetella pertussis Infection: Pathogenesis, Diagnosis, Management, and the Role of Protective Immunity , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[11]  F. Müller,et al.  Laboratory diagnosis of pertussis: state of the art in 1997 , 1997, Journal of clinical microbiology.

[12]  J. Liese,et al.  Polymerase chain reaction (PCR) compared with conventional identification in culture for detection of Bordetella pertussis in 7153 children. , 1997, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  P. Mastrantonio,et al.  Polymerase chain reaction for the detection of Bordetella pertussis in clinical nasopharyngeal aspirates. , 1996, Journal of medical microbiology.

[14]  A. Bollen,et al.  Recommendations for use of the polymerase chain reaction in the diagnosis of Bordetella pertussis infections. , 1994, Journal of medical microbiology.

[15]  S. Halperin,et al.  Identification of Bordetella pertussis infection by shared-primer PCR , 1994, Journal of clinical microbiology.

[16]  N. Cadieux,et al.  Use of a triplex polymerase chain reaction for the detection and differentiation of Mycoplasma pneumoniae and Mycoplasma genitalium in the presence of human DNA. , 1993, Journal of general microbiology.

[17]  W. McPheat,et al.  Identification of Bordetella pertussis in nasopharyngeal swabs by PCR amplification of a region of the adenylate cyclase gene. , 1993, Journal of medical microbiology.

[18]  J. Paton,et al.  Analysis of a repetitive DNA sequence from Bordetella pertussis and its application to the diagnosis of pertussis using the polymerase chain reaction , 1990, Journal of clinical microbiology.

[19]  S. Houard,et al.  Specific identification of Bordetella pertussis by the polymerase chain reaction. , 1989, Research in microbiology.

[20]  I. Onorato,et al.  Laboratory diagnosis of pertussis: the state of the art , 1987, The Pediatric infectious disease journal.